Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for POCI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 -0.7233M
December 31, 2025 -0.2561M
September 30, 2025 0.0782M
June 30, 2025 -0.5942M
March 31, 2025 -1.873M
December 31, 2024 -0.7868M
September 30, 2024 -0.3336M
June 30, 2024 -0.976M
March 31, 2024 -0.2142M
December 31, 2023 -0.1198M
September 30, 2023 -1.373M
June 30, 2023 -0.6298M
March 31, 2023 0.5093M
December 31, 2022 -0.1826M
September 30, 2022 0.1997M
June 30, 2022 -0.0534M
March 31, 2022 -0.1648M
December 31, 2021 -0.5588M
September 30, 2021 -0.1823M
June 30, 2021 0.122M
March 31, 2021 0.142M
December 31, 2020 -0.0448M
September 30, 2020 -0.1726M
June 30, 2020 -0.5081M
March 31, 2020 0.3849M
Date Value
December 31, 2019 -0.4706M
September 30, 2019 0.0013M
June 30, 2019 -0.0776M
March 31, 2019 -0.3766M
December 31, 2018 -0.5711M
September 30, 2018 -0.0064M
June 30, 2018 0.2074M
March 31, 2018 -0.1748M
December 31, 2017 0.1996M
September 30, 2017 -0.1316M
June 30, 2017 -0.0355M
March 31, 2017 -0.3525M
December 31, 2016 -0.4372M
September 30, 2016 0.1578M
June 30, 2016 -0.1261M
March 31, 2016 -0.2253M
December 31, 2015 -0.3998M
September 30, 2015 -0.1251M
June 30, 2015 -0.049M
March 31, 2015 -0.0646M
December 31, 2014 -0.069M
September 30, 2014 -0.5912M
June 30, 2014 -0.2172M
March 31, 2014 -0.2192M
December 31, 2013 -0.3026M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
RxSight, Inc. -9.538M
Abbott Laboratories 2.488B
Align Technology, Inc. 192.76M
AngioDynamics, Inc. 17.45M
Accuray, Inc. --